Department of Medical Microbiology, University of Manitoba, H3440-1015 Arlington St., Winnipeg, MB R3E 3R2 Canada.
J Virol. 2011 Feb;85(3):1275-86. doi: 10.1128/JVI.01707-10. Epub 2010 Nov 17.
The limited success of HIV vaccine candidates to date highlights our need to better characterize protective cell-mediated immunity (CMI). While HIV-specific CD8(+) T cell responses have been defined largely by measuring gamma interferon (IFN-γ), these responses are not always protective, and it is unclear whether the same epitopes would predominate if other functional parameters were examined. Here, we assessed the epitope specificity of HIV-specific CD8(+) T cell responses by multiparametric flow cytometry, measuring five CD8(+) T cell functions (IFN-γ, macrophage inflammatory protein 1β [MIP-1β], tumor necrosis factor alpha [TNF-α], interleukin-2 [IL-2], and proliferative capacity) in 24 chronically HIV-infected individuals. Sixty-nine epitope-specific responses to 50 epitopes within p24 were measured. Surprisingly, most epitope-specific responses were IFN-γ negative (50/69 responses). Many responses had polyfunctional (33%) and proliferative (19%) components. An inverse association between IL-2 and proliferation responses was also observed, contrary to what was described previously. We confirm that long-term nonprogressors (LTNP) have more polyfunctional responses and also have higher-magnitude and broader p24-specific proliferation and higher levels of IL-2 and TNF-α production than do progressing controls. Together, these data suggest that the specificity of CD8(+) T cell responses differs depending on the immunological readout, with a 3.5-fold increase in breadth detected by including multiple parameters. Furthermore, the identification of epitopes that elicit polyfunctional responses reinforces the need for the comprehensive evaluation of HIV vaccine candidates, and these epitopes may represent novel targets for CMI-based vaccines.
迄今为止,HIV 疫苗候选物的有限成功突出表明,我们需要更好地描述保护性细胞介导的免疫(CMI)。虽然 HIV 特异性 CD8(+)T 细胞反应主要通过测量γ干扰素(IFN-γ)来定义,但这些反应并不总是具有保护性的,并且不清楚如果检查其他功能参数,是否会优先出现相同的表位。在这里,我们通过多参数流式细胞术评估了 HIV 特异性 CD8(+)T 细胞反应的表位特异性,在 24 名慢性 HIV 感染者中测量了五种 CD8(+)T 细胞功能(IFN-γ、巨噬细胞炎症蛋白 1β [MIP-1β]、肿瘤坏死因子 alpha [TNF-α]、白细胞介素 2 [IL-2]和增殖能力)。测量了针对 p24 内 50 个表位的 69 个表位特异性反应。令人惊讶的是,大多数表位特异性反应为 IFN-γ 阴性(50/69 反应)。许多反应具有多功能(33%)和增殖(19%)成分。还观察到 IL-2 和增殖反应之间的负相关,这与以前的描述相反。我们证实,长期非进展者(LTNP)具有更多的多功能反应,并且具有更高幅度和更广泛的 p24 特异性增殖以及更高水平的 IL-2 和 TNF-α产生,而进展控制者则没有。这些数据共同表明,CD8(+)T 细胞反应的特异性取决于免疫反应的读数,通过包括多个参数,检测到广度增加了 3.5 倍。此外,鉴定出引发多功能反应的表位,这进一步证明了需要对 HIV 疫苗候选物进行全面评估,并且这些表位可能代表基于 CMI 的疫苗的新靶标。